Agilent Technologies Inc. is collaborating with researchers at tw...
Syntegon Technology is the new name among the market leaders in the pr...
The brain is a sort of fortress, equipped with barriers designed to ke...
UK based company Sygnature Discovery has further strengthened its DMPK...
ProBioGen AG and Lava Therapeutics B.V. announced the c...
GenScript Biotech Corp., a leading global biotechnology group an...
BioMed X has announced the start of a new joint research group in...
Exonate, a privately held, early stage, biotech company spun out of th...
NBE-Therapeutics AG announces the closing of a USD 22M Series C financ...
Indapta Therapeutics, Inc., a biotechnology company focused on develop...
MedLever announced that it has signed an agreement with RaySearch Labo...
Blueprint Medicines Corporation, a precision therapy company focused o...
BioMed X has announced the start of a new joint research group in...
Schrödinger and Bayer have announced a five-year technology allia...
Lannett Company, Inc. has commenced marketing Venlafaxine Extended Rel...
ProBioGen AG has signed a commercial license agreement with Roche...
genOway, a leading company in the development of genetically modified ...
UK based MiNA Therapeutics has announced the initiation of a research ...